In this video, Marlise R. Luskin, MD, MSCE, discusses results from a phase 3 randomized trial that investigated the addition of blinatumomab to standard chemotherapy for pediatric B-cell acute ...

In this video, Marlise R. Luskin, MD, MSCE, highlights updates from two groups evaluating blinatumomab and ponatinib for the treatment of acute lymphoblastic leukemia.

Regardless of country-level income classification, medications for the secondary prevention of CVD remains underutilized and ...

Nearly 50% of women who utilized antidepressant prescriptions before conception discontinued use after pregnancy without ...

There are multiple strategies that physicians and clinicians can use to address the important issue of vaccine hesitancy. But let me start first by defining exactly what vaccine hesitancy is. There's ...

Also, if you're more of a mobile app user, there is a CDC Vaccine Schedules app, which can be downloaded, and that can be utilized on your mobile device for easy access as a resource to help keep up ...

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

In this video, Xiuning Le, MD, PhD, discusses the state of the pipeline for developing EGFR-mutated lung cancer treatments.

In this video, Xiuning Le, MD, PhD, discusses how the definition of EGFR-mutated lung cancer has expanded in recent years.

In this video, Xiuning Le, MD, PhD, discusses some of the latest developments in the study and treatment of EGFR-mutated lung cancer.

In this video, Xiuning Le, MD, PhD, discusses the greatest areas of unmet need in the treatment of EGFR-mutated lung cancer.

In this video, Xiuning Le, MD, PhD, discusses how she approaches putting together a treatment plan for a patient with EGFR-mutated lung cancer.